Syneos Health_rgb_r.jpg
INC Research to Present at Upcoming Jefferies Global Healthcare Conference
May 31, 2017 16:31 ET | INC Research, LLC
RALEIGH, N.C., May 31, 2017 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading global Phase I to Phase IV contract research organization, today announced that Chief Executive...
Syneos Health_rgb_r.jpg
INC Research and inVentiv Health to Merge
May 10, 2017 06:03 ET | INC Research, LLC
Creates a Leading Global Biopharmaceutical Solutions Organization with Combined Net Revenue of More Than $3.2 Billion Combined Company Will Be Second Largest Biopharmaceutical Outsourcing Provider,...
Syneos Health_rgb_r.jpg
INC Research Reports First Quarter 2017 Results
May 10, 2017 06:00 ET | INC Research, LLC
Highlights Book-to-bill ratio of 1.4x for the first quarter of 2017 and 1.2x for the twelve-month period ended March 31, 2017.Net new business awards of $359.9 million for the three months ended...
Syneos Health_rgb_r.jpg
INC Research is the First CRO to obtain IAOCR’s Silver Workforce Quality Accreditation Status
April 25, 2017 10:00 ET | INC Research, LLC
RALEIGH, N.C., April 25, 2017 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading global Phase I to IV contract research organization, and IAOCR, the accrediting organization...
Syneos Health_rgb_r.jpg
INC Research Schedules First Quarter 2017 Earnings Call for Wednesday, May 10, 2017
April 20, 2017 17:25 ET | INC Research, LLC
RALEIGH, N.C., April 20, 2017 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading, global Phase I to IV contract research organization, will release its first quarter 2017...
Syneos Health_rgb_r.jpg
INC Research Bolsters Support for Vaccine Trials through Expanded Site and Patient Initiatives
April 06, 2017 14:52 ET | INC Research, LLC
RALEIGH, N.C., April 06, 2017 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading global Phase I to IV contract research organization, will demonstrate its continued commitment...
Syneos Health_rgb_r.jpg
INC Research Ranked “Top CRO to Work With” Among Top 10 Global CROs for Third Consecutive Time in Biannual CenterWatch Survey
April 03, 2017 07:47 ET | INC Research, LLC
Survey ranking reinforces Company’s industry-leading position as CRO of Choice for sitesOnly company to rank consistently among top three CROs in every survey over the last decadeCompany rated a top...
Syneos Health_rgb_r.jpg
INC Research Reports Fourth Quarter and Full Year 2016 Results
February 28, 2017 06:26 ET | INC Research, LLC
Highlights  Book-to-bill ratio of 1.1x and 1.2x for the fourth quarter and full year 2016, respectively.Net new business awards of $289.6 million and $1.22 billion for the fourth quarter and...
Syneos Health_rgb_r.jpg
INC Research to Present at Upcoming Nasdaq Investor Conference
November 14, 2016 16:15 ET | INC Research, LLC
RALEIGH, N.C., Nov. 14, 2016 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading global Phase I to Phase IV contract research organization, today announced that Chief...
Syneos Health_rgb_r.jpg
INC Research Selected to Manage The Leukemia & Lymphoma Society’s First-ever Master Trial to Advance New Targeted Therapies for Acute Myeloid Leukemia
November 07, 2016 11:15 ET | INC Research, LLC
RALEIGH, N.C., Nov. 07, 2016 (GLOBE NEWSWIRE) -- INC Research Holdings, Inc. (Nasdaq:INCR), a leading, global Phase I to IV contract research organization, today announced its involvement in The...